<DOC>
	<DOCNO>NCT02598349</DOCNO>
	<brief_summary>The prognosis patient localize pancreatic adenocarcinoma surgical candidate poor . Patients characterize `` borderline resectable '' disease treat preoperative chemo-radiotherapy fair somewhat well - although many patient convert resectability . It may argue intensification local regional therapy might 1 . ) Increase share patient able undergo curative surgery 2 . ) Improve local disease control interval extend survival patient remain unresectable . Therefore , purpose research study determine increase number surgical resection pancreatic adenocarcinoma high historical data use combined treatment proton radiation capecitabine ( oral chemotherapy ) .</brief_summary>
	<brief_title>Proton Radiation Unresectable , Borderline Resectable , Medically Inoperable Carcinoma Pancreas ( PC04 )</brief_title>
	<detailed_description>Participants part research study receive Proton radiation 6 week oral chemotherapy ( capecitabine ) take radiation day . In addition , If surgery option , surgical resection perform least 8 week treatment radiation chemotherapy . Quality Life questionnaires part study.The Fact-Hep questionnaire fill participant strategic time point treatment course .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Biopsy proven unresectable adenocarcinoma pancreas . Have either unresectable , borderline resectable medically inoperable carcinoma pancreas , refuse surgery . A biliary obstruction able participate long drainage tube place prior start treatment Proton radiation , Participants childproducing potential must willing use contraception treatment least 12 month thereafter . Required pretreatment laboratory parameter : Absolute granulocyte count ( AGC/ANC ) ≥ 1.8 thou/mm3 Platelet count ≥ 100,000/mm3 Bilirubin &lt; 2 mg/dl ALT/SGPT &lt; 3x upper limit normal Creatinine &lt; 3 mg/dl Evidence distant metastasis . Prior surgical resection . Previous history invasive malignancy ( except nonmelanoma skin cancer low intermediate risk prostate cancer ) unless participant disease free 5 year prior registration . Active untreated infection , Pregnant breastfeed woman subject child produce potential willing use medically acceptable contraception treatment least 12 month thereafter . Previous Radiation abdomen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Unresectable</keyword>
	<keyword>Borderline resectable</keyword>
</DOC>